Home / Clindamycin / Belgium
BE ATC J01FF01 · updated 2 Nov 2026
Clindamycin shortage in Belgium
Is there a Clindamycin shortage in Belgium?
Yes. As of 2 Nov 2026, 1 Clindamycin product is reported short in Belgium, the first since 17 Sep 2026. The company estimate for the return is 10 Jan 2027. Main reason: manufacturing problem.
Also short in United States, Canada, France, Italy, Ireland, Switzerland, Czechia, Australia. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Clindamycine Fresenius Kabi 150 mg/ml inj. sol. i.m./i.v. amp. 10 x 2 ml | Fresenius Kabi | 17 Sep 2026 | 10 Jan 2027 | Manufacturing problem Delay in production |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.